Molecular Diagnostics in Infectious Disease Testing Market
Molecular Diagnostics in Infectious Disease Testing
Market Scope: Industry Analysis, Market Size,
Growth, Trends Till 2031
Request Sample Report
Molecular Diagnostics in Infectious Disease Testing
Market Size and Growth
The Molecular Diagnostics in Infectious Disease Testing market is projected to grow significantly, driven by increased demand for rapid and accurate testing. The market size is estimated to reach approximately $8 billion by 2025, fueled by advancements in technology and rising incidences of infectious diseases worldwide. Robust regulatory frameworks enhance market dynamics. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Abbott
◍ BD
◍ BioMerieux
◍ Thermo Fisher Scientific
◍ Roche
◍ Siemens
◍ Veridex
◍ Luminex
◍ GenMark Diagnostics
◍ Qiagen
◍ Genomix Biotech
◍ BioTheranostics
The Molecular Diagnostics in Infectious Disease Testing Market features key players like Abbott, BD, BioMerieux, and Roche, utilizing advanced technologies for rapid pathogen detection. These companies drive market growth through innovative product development and strategic partnerships. Sales figures highlight their robust market presence, with significant revenue contributions enhancing diagnostic capabilities.
Request Sample Report
Market Segmentation
By Application
Hospitals ◍ Clinics
◍ Academic Institutes ◍ Laboratories ◍ Others
By Product
◍ Polymerase Chain Reaction (PCR)
◍ Isothermal Nucleic Acid Amplification Technology (INAAT)
◍ Microarrays
◍ Next-Generation Sequencing (NGS)
◍ Hybridization ◍ Others
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
